Case : The glaucoma consult Case: The Glaucoma Consult Case: The Glaucoma Consult Case : The Glaucoma Consult Case : The weekend call you don t want

Similar documents
DISCLOSURE: What to do? 2/22/2016

How Strongly Do You Feel That This Patient Has Glaucoma? % % % % %

My Favourite Cases Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD

Ocular Manifestations of Systemic Disease: Grand Rounds Kimberly K. Reed, O.D., FAAO

Interesting, unusual and eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN

Moncef Khairallah, MD

Interesting, unusual, eclectic cases from 2017 Robert A. Mittra, MD VitreoRetinal Surgery, P.A. Minneapolis, MN

NEPTUNE RED BANK BRICK

Mark Dunbar: Disclosure

Past ocular history. DME Case 1. Patient presents blurred VA. Hemoglobin A1c 11.5% -- patient states sugars have not been in good control

You can C-ME after Uveitis

Evaluation of ONH Pallor in Glaucoma Patients and Suspects. Leticia Rousso, O.D. Joseph Sowka, O.D

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

10/3/2018. Case: 63 year old white female 6/11/2012 visit. Glaucoma Update for the Primary Care OD CHRISTOPHER WOLFE, OD, FAAO, DIPL ABO

Optometric Postoperative Cataract Surgery Management

Grand Rounds Clinical Cases from Alex D. Gibberman, O.D. Harpers Point Eye Associates

Tiffany L. Kruger, D.O. Children s Hospital of Michigan Wayne State University/Kresge Eye Institute

Vascular Disease Ocular Manifestations of Systemic Hypertension

Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)

Practical Care of the Cataract Patient with Retinal Disease

Intravitreal Injection

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Billing Requirements for Intravitreal Injections. Financial Interest. Indications. Documentation. Documentation. Documentation

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Dr. Litwak is on the speaker bureau and advisory panel for Alcon and Zeiss Meditek

A Curious Case of Bilateral Optic Disc Edema Brittney Dautremont, DO, MPH

COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY

30 Years of Clinical Challenges

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

Progressive Symptomatic Retinal Detachment Complicating Retinoschisis. Initial Reporting Questionnaire

84 Year Old with Rosacea

FRANZCO, MD, MBBS. Royal Darwin Hospital

FA Conference. Lara Rosenwasser Newman, M.D. 10/2/14 University of Louisville Department of Ophthalmology and Visual Sciences

1/25/2018. Case Management Strategies in Diabetic Retinopathy. Case Study #1: Severe DME. DDOS: 3/31/2016 Va 20/400. Disclosures

VITREOMACULAR UPDATE FOR THE PRIMARY CARE OD

Grand Rounds. Eddie Apenbrinck M.D. University of Louisville School of Medicine Department of Ophthalmology & Visual Sciences 6/20/2014

Clinically Significant Macular Edema (CSME)

A Patient s Guide to Diabetic Retinopathy

Update on management of Anterior Uveitis

Disclosures. How small?

An Injector s Guide to OZURDEX (dexamethasone intravitreal implant) 0.7 mg

Financial Interest. Financial Interest. Minor Procedures. Modifier -25. Minor Procedures & Office Visits

Surgery in patients with uveitis. Lyndell Lim and Anthony Hall

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Diabetic Retinopathy Screening Program in the Cree Region of James Bay of Quebec


Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Cataract surgery is the leading cause of malpractice claims (OMIC) Complicated CE/IOL: Choices the anterior segment surgeon can make

EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA

Brampton Hurontario Street Brampton, ON L6Y 0P6

Tuberous sclerosis presenting as atypical aggressive retinal astrocytoma with proliferative retinopathy and vitreous haemorrhage

Vanderbilt Eye Institute Clinical Trials

Is this glaucoma? Leo Semes, OD Michael Chaglasian, OD Danica Marrelli, OD. Optometry s Meeting 2015 Seattle, WA

Age-Related Macular Degeneration (AMD)

Comparison of management options for scleral buckle exposure

Neuro Ocular Grand Rounds Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD

Optometry Student Extern Manual. Miami VA Medical Center

PRECISION PROGRAM. Injection Technique Quick-Reference Guide. Companion booklet for the Video Guide to Injection Technique

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

Ophthalmology Macular Pathways

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

Patient AB. Born in 1961 PED

Documentation Challenges

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Goals/Objectives. Disclosures. Risk Factors RAO and RVO. Risk Factors. Retinal Artery Occlusions Branch and Central

ABCs. ABCs of retinal disease !"#$"%!& Disclosures. ABCs three major threats to vision where 1 o care intervention may be helpful!a = AMD !

Diabetic Retinopatathy

CASE PRESENTATION. DR.Sravani 1 st yr PG Dept of Ophthalmology

OCULAR MANIFESTATIONS OF SYSTEMIC DISEASES THUCANH MULTERER, MD

Diabetic Retinopathy

OCT Angiography The Next Frontier

Neuro-Ocular Grand Rounds Anthony B. Litwak,OD, FAAO VA Medical Center Baltimore, Maryland

Venous Occlusive Diseases

Imaging in uveitis. Anthony Hall

2016 PQRS Recommended Measures for: Ophthalmology

Sahand Ensafi PA, CCPA, B.H.Sc.,Department of Emergency Medicine, University Health Network

Clinical Study Intravitreal Dexamethasone in the Management of Delayed-Onset Bleb-Associated Endophthalmitis

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

9/23/2014. Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014

Neuro-Ocular Grand Rounds

Retinal Imaging Conference. Brooke LW Nesmith, M.D. University of Louisville Department of Ophthalmology and Visual Sciences 8/7/2014

Case Follow Up. Sepi Jooniani PGY-1

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Optometry Student Extern Manual. Miami VA Medical Center

My Doc told me I needed an eye exam because.. Bruce Onofrey, OD, RPh, FAAO Professor, U. Houston UEI

Patient 1. Grand Rounds. Medical History. Ocular History. Medications. Exam 10/28/ year old African American male. Blur OD x 3 months

Case #1: 68 M with floaters OS

Retinal Vein Occlusion


Intro to Glaucoma/2006

Retinal Diseases. Age-Related Macular Degeneration. What Is AMD? Risk Factors for AMD

Treatment of Retinal Vein Occlusion (RVO)

Cataract surgery: from less drops to drop less.

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Transcription:

1 2 3 4 5 6 Case : The glaucoma consult CC: second opinion on glaucoma HPI: OU/ 1 mos/optometrist thinks I have glaucoma/ no Rx yet / no POAG family hx 62 BM, VA OD = 20/40, VA OS = 20/30 NS +1 IOP: 20 11:00 am OU Pach: 574u VF OD: reliable / abn PD / hemifield zone defect VF OS: reliable / abn PD / hemifield depression OCT: CDR 0.8 OD / 0.70 OS Abn quadrant defects, abn RNFL OU, Abn cup volume OD Case: The Glaucoma Consult IMP: POAG OU Plan: Start latanoprost 0.005% qhs OU, RTO 3 weeks Next visit IOP is 19/19..and tolerated RTO 4 months LOOK AGAIN Case: The Glaucoma Consult IMP: VF are suggestive of a chiasmal compressive lesion, most likely pituitary adenoma ROS: negative HA: negative Call PCP and arrange for MRI of brain Results massive supracellar pituitary adenoma with extension and bone erosion Plan - neurosurgery Case : The Glaucoma Consult Pearls Optic nerve cupping can be glaucomatous or non-glaucomatous Tumors involving the visual pathways will cause VFDs Most glaucoma VFDs are nasal Too much information can be misleading Case : The weekend call you don t want CC: lost vision since yesterday HPI: OS/1 day/constant/decreased vision Cat-IOL/OS post op day 3, Cipro qid & prednisolone qid, no pain Offered to bring to office; pt declined; follow up appointment moved up to Monday (4 days after surg) 67 F, VA OD = 20/40, VA OS = LP, was 20/80 dilated at same day post-op visit PCIOL OS IOP: 10 OU Hypopion inferiorly in anterior chamber

7 8 9 10 11 Case : The weekend call IMP: exogenous endophthalmitis OS PLAN: Retina consult STAT, NPO, schedule for same day pars plana vitrectomy, Early Vitrectomy Study (EVS) LP = PPV, better than LP = AC tap, Vit tap and injection AC tap/culture, vitreous tap/culture, intravitreal antibiotic (vancomycin & ceftazidime), intravitreal steroid (dexamethasone) Switch to different topical antibiotic (moxifloxacin) Tests results Bacterial culture low growth of staphylococcus Sensitivity resistant to ciprofloxacin, sensitive to others Post-operative course was resolution of infection and corneal edema, followed by another retina procedure to wash-out vitreous for heavy floaters/opacities Uncorrected VA of 20/30 Case: The Weekend Call Pearls Presents on day 3 to week 3 after eye surgery Common complaints are decreased vision after initial improvement, and pain Incidence is 0.01% of all cataract surgeries Start topical antibiotics 1-3 days prior to surgery Then betadine lavage at surgery (antiseptic) Prognosis often poor if delay in diagnosis VA = 20/40 in 75% if identified early and aggressively treated with antibiotics that work We are running out of antibiotics!!! Case : The Blurry after LASIK CC: Blurry HPI: OU/4y/mod/LASIK OU 14 yrs ago 33 F, Meds: none MR OD: -1.25-1.25x65 = 20/30 MR OS: -1.50-0.50x105 = 20/25 IOP: 14OU AC: D&Q Color: OD 13/15, OS 9/15 Retina: white lesions punched out, foveal atrophy OCT: OD 381u, OS 375u +CME, +SRF IVFA: cap drop out, multiple vascular staining and leakage, petalloid macular leakage IMP Retinal vasculitis OU, etiology unknown PLAN PE with PCP Labs CBC w differential, C-reactive protein, Anti-nuclear antibody,

12 13 14 15 16 Angiotensin converting enzyme, Rapid plasma reagin, erythrocyte sedimentation rate, metabolic panel Consult retina order Brain MRI IMP Retinal vasculitis OU, etiology unknown PLAN Subtenon s depo-medrol OS CBC w differential - nl C-reactive protein - nl Anti-nuclear antibody - nl Angiotensin converting enzyme - nl Rapid plasma reagin - nl Erythrocyte sedimentation rate nl Metabolic panel - nl Brain MRI posterior basilar vasculitits (MS?) OCT pearls IVFA and OCT both reach same conclusion Both tests are abnormal No surprises CC: Had cataract surgery and cant see HPI: OS/1m/Cat-IOL/OD gave 2 new glasses, likes one better than other 80 F, VA OD = 20/30, VA OS = 20/40+ at one week post ops, admits to one drop per day? PCIOL OU IMP Pseudophakic OU PLAN Predforte tid OU, release to optometrist for continued care, emphasis on correct drug dosing CC: Had cataract surgery and cant see HPI: OS/1m/Cat-IOL/OD gave 2 new glasses, likes one better than other Now after one month VA OD = 20/200 OS Hands me the steroid prescription (never filled) PCIOL OU IMP Pseudophakic CME OS? OCT: OD 311u, OS 510u Plan: Retina for IVK (failure with drop compliance) OCT Pearls OCT demonstrates abnormal thickness OS IVFA not needed to confirm diagnosis Pseudophakic CME in this case related to inflammation from noncompliance with steroidal eyedrops

17 18 19 20 21 22 Treatment with topicals may be beneficial but with questionable ability to comply, intraocular depot drug is the best choice Case: The Big Black Spot CC: Black spot HPI: OS/2 days/constant/decreased vision Cat- IOL/OU ROS: recent diagnosis Hairy cell leukemia, chemotherapy and spleenectomy, now anemic 76 F, VA OD = 20/40, VA OS = 20/400, was 20/25 two months prior PCIOL OU IOP: 10 OU Fundus: peripheral small retinal hemorrhages OU, thick macular hemorrhage OS, schisis cavity inf OS OCT: 286u/333u Case: The Big Black Spot IMP: Leukemic Retinopathy PLAN: Retina consult TPA & gas to displace macular hemorrhage Continue oncologic care Follow-up visit one month RE 20/25 LE 20/30 No retinopathy noted! Case: The Leukemic Retina Pearls OCT demonstrates abnormal thickness OS OCT clearly shows pre-retinal and intra-retinal nature of hemorrhages Prognosis often very good Case: Upper part missing 65yowm referred for AION CC: wavy things HPI: OD / 5 wks wavy / 2 wks upper part of vision missing / no pain / no flashes Meds: MV, OM3, ASA NKDA BVA: HM OD, 20/25 OS PERRL No APD EOM: Full EXT: W&Q SLE: NS 2 OU IOP: 15 OU Fundus: as pictured What is the likely diagnosis? 1. Retinal tear/detachment 2. Lattice degeneration 3. Vitreous hemorrhage 5. Benign choroidal nevus 6. Malignant melanoma What is the best course now? 1. Retina consult, surgery

23 24 25 26 27 28 2. Ocular Oncology 3. PCP Case: Fell & Hit head 89yowm MD referred for RD CC: retina problem HPI: OS / 1 wk / no pain / no flashes / no vision loss Meds: levothyroxine, OM3, garlic NKDA BVA: 20/50, 20/60 OS PERRL No APD EOM: Full EXT: W&Q SLE: PCIOL OU IOP: 15 OU Fundus: as pictured What is the likely diagnosis? 1. Retinal detachment 2. Choroidal detachment 3. Vitreous hemorrhage 5. Macular degeneration 6. Malignant melanoma What is the best course now? 1. Retina detachment surgery 2. Ocular Oncology 3. IVFA and anti- VEGF 4. No Rx; observation Case: 10 days of bad vision 49yowm OD referred for VO CC: Can t see for 10 days HPI: OD / 10 days / no pain / no flashes Meds: amlodipine, OM3, ASA NKDA BVA: CF, 20/20 OS PERRL No APD EOM: Full EXT: W&Q SLE: NL OU IOP: 13 OU Fundus: as pictured BP 190/105 What Options Are Available Now? PCP for immediate assessment of HTN (or ER) Intravitreal steroids Intravitreal Anti-VEGF Focal grid photocoagulation RIDE/RESOLVE studies Lucentis for ME Ozurdex implant